Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

IRBS

IR BioSciences (CE) (IRBS)

IR BioSciences Holdings Inc New (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:IRBS
DatumZeitQuelleÜberschriftSymbolFirma
24/05/201123h28Edgar (US Regulatory)Annual Report (10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
16/05/201121h11Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
31/03/201118h54Edgar (US Regulatory)Notification that Annual Report will be submitted late (NT 10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
10/03/201123h29Edgar (US Regulatory)Current report filing (8-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
22/11/201022h12Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
12/11/201014h27Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
28/10/201015h00GlobeNewswire Inc.ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University CollaborationUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
01/10/201022h37Edgar (US Regulatory)Current report filing (8-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
08/09/201013h00GlobeNewswire Inc.ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
31/08/201020h21GlobeNewswire Inc.ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for InUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
25/08/201015h00GlobeNewswire Inc.University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
23/08/201023h15Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
13/08/201022h12Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
05/08/201014h27Marketwired/ CORRECTION - ImmuneRegen BioSciencesUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
04/08/201013h00MarketwiredImmuneRegen BioSciences Completes Successful Reduction of DebtUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
26/07/201012h01Edgar (US Regulatory)Current report filing (8-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
24/05/201021h40Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
17/05/201017h51Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
30/04/201023h17Edgar (US Regulatory)Amended Annual Report (10-K/A)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
27/04/201014h00MarketwiredImmuneRegen BioSciences(R) Announces Collaboration With the Department of Tumor Immunology of the Radboud University Nijmegen MeUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
21/04/201014h00MarketwiredImmuneRegen BioSciences(R) Initiates Strategic Collaboration With MPI Research to Accelerate Clinical Development of Lead IndicaUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
19/04/201019h00MarketwiredImmuneRegen BioSciences(R) Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic PlanningUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
15/04/201022h20Edgar (US Regulatory)Annual Report (10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
01/04/201022h01Edgar (US Regulatory)Notification that Annual Report will be submitted late (NT 10-K)USOTC:IRBSIR BioSciences Holdings Inc New (CE)
04/03/201014h00MarketwiredImmuneRegen BioSciences Submits Homspera(R) for FDA Orphan Drug Product Designation for the Treatment of Idiopathic Pulmonary FiUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
10/02/201014h00MarketwiredFred Hutchinson Cancer Research Center Initiates Studies on ImmuneRegen BioSciences' Cancer Therapy CandidateUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
27/01/201014h00MarketwiredNational Cancer Institute Initiates Studies on ImmuneRegen BioSciences' Vaccine Adjuvant CandidateUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
26/01/201020h54MarketwiredIR Biosciences' ImmuneRegen (OTCBB: IRBS) Getting Attention for Its Adult Stem Cell Active CompoundUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
05/01/201014h00MarketwiredImmuneRegen BioSciences(R) Reports Additional Positive Results From Study of Homspera(R) in Treating Highly Pathogenic InfluenzaUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
24/12/200914h00MarketwiredImmuneRegen BioSciences(R) Summarizes Previous 9 Months of Advances as Homspera(R) Development ContinuesUSOTC:IRBSIR BioSciences Holdings Inc New (CE)
 Showing the most relevant articles for your search:USOTC:IRBS